Literature DB >> 6319568

Recovery of herpes simplex virus genetic information from human trigeminal ganglion cells following superinfection with herpes simplex virus type 2 temperature-sensitive mutants.

M E Lewis, S M Brown, K G Warren, J H Subak-Sharpe.   

Abstract

Explant cultures of human trigeminal ganglia were derived from 36 individuals. Those cultures which failed to release herpes simplex virus (HSV) spontaneously were superinfected at various times after establishment in vitro with a range of HSV-2 temperature-sensitive (ts) mutants. Eight cultures from six individuals contained HSV-specific genetic information which could be detected or rescued following superinfection. Restriction enzyme analysis of ts+ virus recovered from the ganglia of two individuals following superinfection was identical to that of endogenous HSV-1 spontaneously released from parallel cultures. Retrieval of ts+ virus by this technique suggests products of the superinfecting virus activated expression of whole genomes or that spontaneous virus expression occurred unrelated to the act of superinfection.

Entities:  

Mesh:

Year:  1984        PMID: 6319568     DOI: 10.1099/0022-1317-65-1-215

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

1.  Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli beta-galactosidase.

Authors:  A I Geller; A Freese
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

2.  A defective HSV-1 vector expresses Escherichia coli beta-galactosidase in cultured peripheral neurons.

Authors:  A I Geller; X O Breakefield
Journal:  Science       Date:  1988-09-23       Impact factor: 47.728

3.  A cultured human oligodendroglioma cell line and herpes simplex virus-infected cells share antigenic determinants.

Authors:  P G Kennedy; B A Watkins; N B LaThangue; G B Clements; D G Thomas
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.